Literature DB >> 13991539

Wilson's disease and the concentration of caeruloplasmin in serum.

I H SCHEINBERG, I STERNLIEB.   

Abstract

Entities:  

Keywords:  CERULOPLASMIN; HEPATOLENTICULAR DEGENERATION

Mesh:

Substances:

Year:  1963        PMID: 13991539     DOI: 10.1016/s0140-6736(63)92070-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Fulminant Wilson's disease with haemolysis and renal failure: copper studies and assessment of dialysis regimens.

Authors:  A N Hamlyn; J L Gollan; A P Douglas; S Sherlock
Journal:  Br Med J       Date:  1977-09-10

2.  Reduced oxidase activity in the caeruloplasmin of two families with Wilson's disease.

Authors:  J L Gollan; J Stocks; T L Dormandy; S Sherlock
Journal:  J Clin Pathol       Date:  1977-01       Impact factor: 3.411

3.  Hudson memorial lecture: Wilson's disease: genetics and biochemistry--their relevance to therapy.

Authors:  J M Walshe
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

4.  [Quantitative determination and phenotyping of ceruloplasmin in morbus Wilson (author's transl)].

Authors:  H W Goedde; H G Benkmann; J Lange; H Harders
Journal:  Klin Wochenschr       Date:  1975-08-01

5.  Ceruloplasmin in Wilson's disease.

Authors:  N A Holtzman; M A Naughton; F L Iber; B M Gaumnitz
Journal:  J Clin Invest       Date:  1967-06       Impact factor: 14.808

6.  An assessment of efficiency in potential screening for Wilson's disease.

Authors:  T Saito
Journal:  J Epidemiol Community Health       Date:  1981-12       Impact factor: 3.710

Review 7.  [Ceruloplasmin. I. Biochemistry of ceruloplasmin. II. Influence of estrogens on the ceruloplasmin content of the serum].

Authors:  A W Mondorf; G Mackenrodt; E Halberstadt
Journal:  Klin Wochenschr       Date:  1971-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.